{"pmid":32419737,"pmcid":"PMC7225701","title":"[Asthma and COVID-19: a risk population?]","text":["[Asthma and COVID-19: a risk population?]","Rev Mal Respir","Underner, M","Peiffer, G","Perriot, J","Jaafari, N","32419737"],"journal":"Rev Mal Respir","authors":["Underner, M","Peiffer, G","Perriot, J","Jaafari, N"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419737","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.rmr.2020.05.002","topics":["Prevention"],"weight":1,"_version_":1667254896805543940,"score":9.490897,"similar":[{"pmid":32358994,"title":"Asthma and COVID-19: is asthma a risk factor for severe outcomes?","text":["Asthma and COVID-19: is asthma a risk factor for severe outcomes?","When I first read the manuscript that accompanies this editorial, upon its online publication on February 19(th) 2020(1), COVID-19 had already killed 2118 people in China, but only one person in Europe - an 80-year-old tourist from China, who died in France on the 15(th) February. I read the manuscript with grim fascination, as it was clear that SARS-CoV-2 had spread very rapidly in China which already had 74,576 cases and in South Korea which already had 58 cases, and that it was then invading Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countries too.","Allergy","Johnston, Sebastian L","32358994"],"abstract":["When I first read the manuscript that accompanies this editorial, upon its online publication on February 19(th) 2020(1), COVID-19 had already killed 2118 people in China, but only one person in Europe - an 80-year-old tourist from China, who died in France on the 15(th) February. I read the manuscript with grim fascination, as it was clear that SARS-CoV-2 had spread very rapidly in China which already had 74,576 cases and in South Korea which already had 58 cases, and that it was then invading Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countries too."],"journal":"Allergy","authors":["Johnston, Sebastian L"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358994","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/all.14348","keywords":["covid-19","asthma"],"locations":["China","China","France","China","South Korea","France","Germany","GBR","Italy","Spain"],"countries":["Germany","Korea, Republic of","Spain","United Kingdom","China","Italy","France"],"countries_codes":["DEU|Germany","KOR|Korea, Republic of","ESP|Spain","GBR|United Kingdom","CHN|China","ITA|Italy","FRA|France"],"topics":["Treatment","Prevention","Diagnosis"],"weight":1,"_version_":1666138495304859649,"score":49.056534},{"pmid":32371563,"title":"Asthma increases risk of severity of COVID-19.","text":["Asthma increases risk of severity of COVID-19.","Current Centers for Disease Control and Prevention guidelines state that patients with moderate to severe asthma may be at greater risk for more severe disease if infected with SARS-CoV-2; however, no published data support this suggestion. During this pandemic, it is recommended that patients with asthma continue taking all controller inhalers and other asthma medication as prescribed to prevent exacerbations and limit outpatient clinic and emergency room exposure. Symptoms that may differentiate COVID-19 from asthma exacerbations caused by another trigger may include fever, fatigue, anorexia, or myalgias. Patients with suspected or confirmed COVID-19 should avoid nebulizer treatments due to the risk of aerosolization.","Cleve Clin J Med","Pennington, Emily","32371563"],"abstract":["Current Centers for Disease Control and Prevention guidelines state that patients with moderate to severe asthma may be at greater risk for more severe disease if infected with SARS-CoV-2; however, no published data support this suggestion. During this pandemic, it is recommended that patients with asthma continue taking all controller inhalers and other asthma medication as prescribed to prevent exacerbations and limit outpatient clinic and emergency room exposure. Symptoms that may differentiate COVID-19 from asthma exacerbations caused by another trigger may include fever, fatigue, anorexia, or myalgias. Patients with suspected or confirmed COVID-19 should avoid nebulizer treatments due to the risk of aerosolization."],"journal":"Cleve Clin J Med","authors":["Pennington, Emily"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371563","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.ccc002","locations":["nebulizer"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666138496354484225,"score":43.76875},{"pmid":32332038,"title":"Asthma and COVID-19.","text":["Asthma and COVID-19.","CMAJ","Abrams, Elissa M","Geert W, 't Jong","Yang, Connie L","32332038"],"journal":"CMAJ","authors":["Abrams, Elissa M","Geert W, 't Jong","Yang, Connie L"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32332038","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1503/cmaj.200617","topics":["Prevention"],"weight":1,"_version_":1666138493934370816,"score":40.470867}]}